Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elizabeth M. Nielson"'
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and transdiagnostic clinical approach to working with patients who are using or considering using psychedelics in any context. The ongoing discussion of psychedelics in academic
Externí odkaz:
https://doaj.org/article/cbf1b26aefbb4d549c10657bc218af89
Autor:
Sara J. Tai, Elizabeth M. Nielson, Molly Lennard-Jones, Riikka-Liisa Johanna Ajantaival, Rachel Winzer, William A. Richards, Frederick Reinholdt, Brian D. Richards, Peter Gasser, Ekaterina Malievskaia
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Introduction: Psychological support throughout psilocybin therapy is mandated by regulators as an essential part of ensuring participants' physical and psychological safety. There is an increased need for specially trained therapists who can provide
Externí odkaz:
https://doaj.org/article/84764cf913e44355aca91d7fdb17173d
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Research on the clinical applications of psychedelic-assisted psychotherapy has demonstrated promising early results for treatment of alcohol dependence. Detailed description of the content and methods of psychedelic-assisted psychotherapy, as it is
Externí odkaz:
https://doaj.org/article/f8ec58ac1d994748a77322530cec8806
Autor:
Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Peter C. Arden, Annie Baker, James C. Bennett, Catherine Bird, Renske E. Blom, Christine Brennan, Donna Brusch, Lisa Burke, Kete Campbell-Coker, Robin Carhart-Harris, Joseph Cattell, Aster Daniel, Charles DeBattista, Boadie W. Dunlop, Katherine Eisen, David Feifel, MacKenzie Forbes, Hannah M. Haumann, David J. Hellerstein, Astrid I. Hoppe, Muhammad I. Husain, Luke A. Jelen, Jeanine Kamphuis, Julie Kawasaki, John R. Kelly, Richard E. Key, Ronit Kishon, Stephanie Knatz Peck, Gemma Knight, Martijn H.B. Koolen, Melanie Lean, Rasmus W. Licht, Jessica L. Maples-Keller, Jan Mars, Lindsey Marwood, Martin C. McElhiney, Tammy L. Miller, Arvin Mirow, Sunil Mistry, Tanja Mletzko-Crowe, Liam N. Modlin, René E. Nielsen, Elizabeth M. Nielson, Sjoerd R. Offerhaus, Veronica O’Keane, Tomáš Páleníček, David Printz, Marleen C. Rademaker, Aumer van Reemst, Frederick Reinholdt, Dimitris Repantis, James Rucker, Samuel Rudow, Simon Ruffell, A. John Rush, Robert A. Schoevers, Mathieu Seynaeve, Samantha Shao, Jair C. Soares, Metten Somers, Susan C. Stansfield, Diane Sterling, Aaron Strockis, Joyce Tsai, Lucy Visser, Mourad Wahba, Samuel Williams, Allan H. Young, Paula Ywema, Sidney Zisook, Ekaterina Malievskaia
Publikováno v:
Goodwin, G M, Aaronson, S T, Alvarez, O, Arden, P C, Baker, A, Bennett, J C, Bird, C, Blom, R E, Brennan, C, Brusch, D, Burke, L, Campbell-Coker, K, Carhart-Harris, R, Cattell, J, Daniel, A, DeBattista, C, Dunlop, B W, Eisen, K, Feifel, D, Forbes, M, Haumann, H M, Hellerstein, D J, Hoppe, A I, Husain, M I, Jelen, L A, Kamphuis, J, Kawasaki, J, Kelly, J R, Key, R E, Kishon, R, Knatz Peck, S, Knight, G, Koolen, M H B, Lean, M, Licht, R W, Maples-Keller, J L, Mars, J, Marwood, L, McElhiney, M C, Miller, T L, Mirow, A, Mistry, S, Mletzko-Crowe, T, Modlin, L N, Nielsen, R E, Nielson, E M, Offerhaus, S R, O’Keane, V, Páleníček, T, Printz, D, Rademaker, M C, van Reemst, A, Reinholdt, F, Repantis, D, Rucker, J, Rudow, S, Ruffell, S, Rush, A J, Schoevers, R A, Seynaeve, M, Shao, S, Soares, J C, Somers, M, Stansfield, S C, Sterling, D, Strockis, A, Tsai, J, Visser, L, Wahba, M, Williams, S, Young, A H, Ywema, P, Zisook, S & Malievskaia, E 2022, ' Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression ', New England Journal of Medicine, vol. 387, no. 18, pp. 1637-1648 . https://doi.org/10.1056/NEJMoa2206443
The New England journal of medicine, 387(18), 1637-1648. MASSACHUSETTS MEDICAL SOC
Goodwin, G M, Aaronson, S T, Alvarez, O, Arden, P C, Baker, A, Bennett, J C, Bird, C, Blom, R E, Brennan, C, Brusch, D, Burke, L, Campbell-Coker, K, Carhart-Harris, R, Cattell, J, Daniel, A, DeBattista, C, Dunlop, B W, Eisen, K, Feifel, D, Forbes, M, Haumann, H M, Hellerstein, D J, Hoppe, A I, Husain, M I, Jelen, L A, Kamphuis, J, Kawasaki, J, Kelly, J R, Key, R E, Kishon, R, Knatz Peck, S, Knight, G, Koolen, M H B, Lean, M, Licht, R W, Maples-Keller, J L, Mars, J, Marwood, L, McElhiney, M C, Miller, T L, Mirow, A, Mistry, S, Mletzko-Crowe, T, Modlin, L N, Nielsen, R E, Nielson, E M, Offerhaus, S R, O'Keane, V, Páleníček, T, Printz, D, Rademaker, M C, van Reemst, A, Reinholdt, F, Repantis, D, Rucker, J, Rudow, S, Ruffell, S, Rush, A J, Schoevers, R A, Seynaeve, M, Shao, S, Soares, J C, Somers, M, Stansfield, S C, Sterling, D, Strockis, A, Tsai, J, Visser, L, Wahba, M, Williams, S, Young, A H, Ywema, P, Zisook, S & Malievskaia, E 2022, ' Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. ', The New England Journal of Medicine, vol. 387, no. 18, pp. 1637-1648 . https://doi.org/10.1056/NEJMoa2206443
The New England journal of medicine, 387(18), 1637-1648. MASSACHUSETTS MEDICAL SOC
Goodwin, G M, Aaronson, S T, Alvarez, O, Arden, P C, Baker, A, Bennett, J C, Bird, C, Blom, R E, Brennan, C, Brusch, D, Burke, L, Campbell-Coker, K, Carhart-Harris, R, Cattell, J, Daniel, A, DeBattista, C, Dunlop, B W, Eisen, K, Feifel, D, Forbes, M, Haumann, H M, Hellerstein, D J, Hoppe, A I, Husain, M I, Jelen, L A, Kamphuis, J, Kawasaki, J, Kelly, J R, Key, R E, Kishon, R, Knatz Peck, S, Knight, G, Koolen, M H B, Lean, M, Licht, R W, Maples-Keller, J L, Mars, J, Marwood, L, McElhiney, M C, Miller, T L, Mirow, A, Mistry, S, Mletzko-Crowe, T, Modlin, L N, Nielsen, R E, Nielson, E M, Offerhaus, S R, O'Keane, V, Páleníček, T, Printz, D, Rademaker, M C, van Reemst, A, Reinholdt, F, Repantis, D, Rucker, J, Rudow, S, Ruffell, S, Rush, A J, Schoevers, R A, Seynaeve, M, Shao, S, Soares, J C, Somers, M, Stansfield, S C, Sterling, D, Strockis, A, Tsai, J, Visser, L, Wahba, M, Williams, S, Young, A H, Ywema, P, Zisook, S & Malievskaia, E 2022, ' Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. ', The New England Journal of Medicine, vol. 387, no. 18, pp. 1637-1648 . https://doi.org/10.1056/NEJMoa2206443
BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression.METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formul
Autor:
Jeffrey Guss, Elizabeth M. Nielson
Publikováno v:
Journal of Psychedelic Studies. 2:64-73
Clinical research on psychedelic-assisted psychotherapy is rapidly advancing in the USA, with two drugs, psilocybin and MDMA, progressing through a structure of FDA-approved trials on a trajectory toward Drug Enforcement Agency rescheduling for thera
Autor:
Elizabeth M. Nielson
Publikováno v:
Journal of Humanistic Psychology. :002216782110212
The therapeutic use of psilocybin in psychedelic-assisted therapy models is currently being tested for a variety of indications, necessitating the training of hundreds of therapists. At present, training programs do not include the provision of a psi
Autor:
Elizabeth M. Nielson
Publikováno v:
Journal of drug and alcohol research
Purpose. The purpose of this paper is to better understand the relationship between substance abuse counselors' personal recov- ery status, self-schemas, and willingness to use empirically supported treatments for substance use disorders. Methods. A